As the nation works to contain the COVID-19 virus, the kidney care community is working tirelessly to protect patients, care providers, and the communities we serve.

KCP-quality-outline

Quality is improving in kidney care. We're just getting started.

About Us

WHO WE ARE

Kidney Care Partners (KCP) was founded in May of 2003 as a coalition of patient advocates, dialysis professionals, care providers, researchers, and manufacturers dedicated to working together to improve quality of care for individuals living with kidney diseases.

icon-1
QUALITY
PRIORITIES
icon-2
Regulatory
Policy
icon-3
Legislative
Agenda

KIDNEY CARE FIRST

A Framework for Improving Renal Disease Support & Treatments

Kidney Care FIRST is a broad look at how we can dramatically improve kidney care nationwide, save lives, and achieve potentially billions of dollars in savings to our healthcare system.

title-kidney-disease

More than 88K Americans are currently waiting for a kidney transplant.

Nearly 500K Americans are currently on dialysis.

More than 700K Americans are living with kidney failure (ESRD).

More than 124K Americans are diagnosed with kidney failure each year.

More than 30M Americans are living with chronic kidney disease.

NEWS

Fierce Healthcare

More attention to patient-centric kidney care policies needed amidst COVID-19 pandemic

Since COVID-19 reached the U.S., normal day-to-day life has come to an unprecedented, screeching halt. While work, school and commerce have slowed, what we have learned—and continue to learn—about COVID-19 is moving at what seems like light speed. Several short months ago, few people were wearing masks in public because we assumed only those individuals…

Read More +

Kidney Care Partners Reacts to Recently Released Prospective Payment System (PPS) Rule

WASHINGTON, DC – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers – today shared the following in reaction to the recently released Prospective Payment System (PPS) Rule: KCP remains supportive of the Transitional Drug Add-on Payment Adjustment (TDAPA) for…

Read More +
The Hill

COVID-19 and kidney disease: A deadly intersection that requires investment in prevention, research

In the months since the novel coronavirus first began infecting individuals in the United States, Americans – health care professionals, researchers, and the public alike – have received a rapid and ever-changing education in the medical science on this devasting virus. What we initially understood as primarily a respiratory illness has proven itself to be…

Read More +